Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The agreement is a broad contract designed to support development efforts and ...

Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The agreement is a broad contract designed to support development efforts and ...

The International Day of Women and Girls in Science is celebrated every February 11 to promote full and equal access to and ...

The 80-year-old partnership between the federal government and research institutions has made the U.S. the leader in ...

The funding pot is being distributed between three projects, aiming to establish new ways of researching how artificial intelligence can be used to target hard-to-treat diseases and develop medicines.

Iris Telehealth, a leading provider of transformative behavioral health services for health systems and community healthcare organizations, today announced that KLAS Research (KLAS®) has named its ...

By sharing the stories of EDI champions in science, we hope to shed light on both the importance of diversity and the ...

Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...

Q4 2024 Earnings Conference Call February 7, 2025 3:00 AM ETCompany ParticipantsNicolas Hieronimus - CEOChristophe Babule ...